Cold Tumors: A Therapeutic Challenge for Immunotherapy

Therapeutic monoclonal antibodies targeting immune checkpoints (ICPs) have changed the treatment landscape of many tumors. However, response rate remains relatively low in most cases. A major factor involved in initial resistance to ICP inhibitors is the lack or paucity of tumor T cell infiltration,...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonaventura, Paola, Shekarian, Tala, Alcazer, Vincent, Valladeau-Guilemond, Jenny, Valsesia-Wittmann, Sandrine, Amigorena, Sebastian, Caux, Christophe, Depil, Stéphane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376112/
https://www.ncbi.nlm.nih.gov/pubmed/30800125
http://dx.doi.org/10.3389/fimmu.2019.00168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376112/
https://www.ncbi.nlm.nih.gov/pubmed/30800125
http://dx.doi.org/10.3389/fimmu.2019.00168

Ejemplares similares